Research funder · United States
Children's Tumor Foundation
Foundation dedicated to improving the health and well-being of individuals and families affected by neurofibromatosis
- Grants since 2016
- 436
- Awarded, last 5 years (where amounts are published)
- 28.1M
- Funded works, last 5 years
- 115
- Funded works, all time
- 426
Grants
2020 · award
Vanderbilt University Medical Center
Paul Moots
2020 · award
Columbia University Medical Center
Wendy Chung
2020 · award
St. Joseph's Regional Medical Center
Punita Gupta
2020 · award
Saint Louis University
Ali Jamal
2020 · award
The Ohio State University
Oliver Adunka
2020 · award
Kentucky Neuroscience Institute Neurofibromatosis Clinic/Chandler Medical Center
Donita Lightner
2020–2022 · award
Malignant Peripheral Nerve Sheath Tumors Achilles Heel: Combinatorial Targeting of ERBB3 and Calcium Signaling
Laurel Black
2020 · award
Texas Children's Hospital
William Craigen
2020–2022 · award
Hexokinase 2 displacement from mitochondria-associated membranes as a new antineoplastic approach in NF1-related tumors
Francesco Ciscato
2020–2022 · award
Impact of PRC2 loss on Glutamine metabolism in MPNSTs
Gavin Mcgivney
2020 · award
Connecticut Children's
Francis Dimario Jr
2020 · award
Boston Children's Hospital
David Miller
2020–2021 · award
Whole body MRI datasets
Wenli Cai
2020 · award
Johns Hopkins University
Jaishri Blakeley
2020 · award
Seattle Children's
Aimee Sato
2019–2020 · award
The impact of Ras/MAPK signaling pathway-targeted therapy (MEK-inhibitor) on neurocognitive functioning in children with NF1
Karin Walsh
2019–2021 · award
A mutation-independent genome editing approach for the treatment of neurofibromatosis type 1 (NF1) using novel AAV vectors
Samantha Ginn · Children's Medical Research Institute
2019–2021 · award
Elucidating the clonal architecture and functional impact of genetic variants in MPNSTs using single cell genomics
Harish Vasudevan
2019–2020 · award
L-carnitine supplementation for NF1 muscle weakness and fatigue.
Aaron Schindeler
2019–2022 · award
Proof of Concept for Gene Therapy in NF2
Michael Wootton · Nf2 Therapeutics, Inc.
2019–2021 · award
Evaluate Novel Hippo-Yap/Taz Inhibitors in Overcoming Therapy Resistance in NF2
Chunling Yi
2019–2021 · award
Evaluation of the use of antisense oligonucleotides as a personalized therapy for Neurofibromatosis Type 2 patients
Elisabeth Castellanos-Perez · Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2019–2020 · award
New Animal Model for Neurofibromatosis Type 2 (characterization of a gene edited NF2 pig model). Shipment of animals to UCLA from Recombinetics
Marco Giovannini
2019–2020 · award
New Animal Model for Neurofibromatosis Type 2 (characterization of a genetically edited NF2 pig model) - Housing of animals for 7 months and MRIs at 12 months of age
Marco Giovannini
2019–2020 · award
Targeting DNA damage signaling and epigenetic deregulation as a combination therapy for malignant peripheral nerve sheath tumors
Keila Torres
2019–2021 · award
Single cell sequencing of glioma in NF1 patients
Antonio Iavarone
2019 · award
NFCN - House Clinic
Gregory Lekovic
2019–2021 · award
Development of NF1 therapeutics with CRISPR-based technologies
James Walker
2019–2022 · award
Cell-free DNA as a biomarker in Neurofibromatosis 1
Raymond Kim
2019 · award
NFCN - John R. Oishei Children's Hospital
Lorna Fitzpatrick
2019–2021 · award
The RABL6A-RB1 pathway in MPNST pathogenesis and therapy
Jordan Kohlmeyer
2018–2019 · award
Exploiting macropinocytosis for the development of exosome-mediated drug delivery in NF2 mutant tumors
Andrea I. Mcclatchey
2018–2020 · award
Genetic and molecular mechanisms of targeted therapy resistance in NF1-associated MPNSTs
Jamie Grit
2018–2019 · award
Reprogramming the Tumor Microenvironment to Enhance Anti-Tumor Immunity in NF2 Vestibular Schwannomas Treatment
Lei Xu
2018–2020 · award
Employing human induced pluripotent stem cells (hiPSCs) to define brain developmental defects in NF1
Michelle Wegscheid
2018–2020 · award
Deciphering and treating ASD-like social behaviour deficits in mouse models for NF1
Sarah Borrie
2018–2019 · award
NFCN - Nemours/Alfred I. duPont Hospital for Children
Karen Gripp
2018–2021 · award
Three-dimensional culture systems to assess the consequences of Nf2/Merlin loss
Evan O'Loughlin
2018–2022 · award
Creation of a NF Data Portal and knowledge database for the scientific community (2018-2021)
Justin Guinney
2018–2019 · award
Dietary Intervention for NF1 Muscle Weakness
Aaron Schindeler